The previously reported candidate gene for response to candesartan, the angiotensin II receptor type 1 gene (AGTR1),29, 30 was not associated with the tested endpoints, except for a possible association with hypotension in the HF with reduced EF patient population. Here, AGTR1 is linked to hydrops fetalis.